Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Guardant Health Inc (NQ: GH ) 33.13 +1.13 (+3.53%) Streaming Delayed Price Updated: 12:00 PM EDT, Jul 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 277,343 Open 32.03 Bid (Size) 33.11 (4) Ask (Size) 33.21 (4) Prev. Close 32.00 Today's Range 31.95 - 33.33 52wk Range 15.81 - 41.06 Shares Outstanding 101,298,669 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Guardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360® Test, Further Extending Its Best-in-Class Performance Today 8:05 EDT From Guardant Health, Inc. Via Business Wire Goldman Sachs Says Buy These 3 Stocks for Double-Digit Returns July 22, 2024 The investment banking firm says these companies are among the best stocks to buy and have some strong tailwinds behind them. Via InvestorPlace Performance YTD +24.97% +24.97% 1 Month +13.89% +13.89% 3 Month +88.35% +88.35% 6 Month +42.68% +42.68% 1 Year -10.41% -10.41% More News Read More 3 Precision Medicine Stocks Tailoring Treatments July 21, 2024 Via InvestorPlace Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast July 18, 2024 Via Benzinga Assessing Guardant Health: Insights From 7 Financial Analysts July 17, 2024 Via Benzinga Where Guardant Health Stands With Analysts June 28, 2024 Via Benzinga Evaluating Guardant Health: Insights From 5 Financial Analysts May 24, 2024 Via Benzinga Dr. Manuel Hidalgo Medina Joins Guardant Health Board of Directors July 18, 2024 From Guardant Health, Inc. Via Business Wire 3 Biotech Moonshots With Imminent Catalyst Potential July 03, 2024 Via InvestorPlace The 3 Best Personalized Medicine Stocks to Buy in July 2024 July 03, 2024 Via InvestorPlace From ‘Sell’ to ‘Strong Buy’: 3 Dramatic Analyst U-Turns to Watch July 02, 2024 Via InvestorPlace Guardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancer June 04, 2024 From Guardant Health, Inc. Via Business Wire Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trials June 03, 2024 From Guardant Health, Inc. Via Business Wire Guardant Health Named to TIME100 Most Influential Companies May 31, 2024 From Guardant Health, Inc. Via Business Wire Guardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer Screening May 30, 2024 From Guardant Health, Inc. Via Business Wire Cathie Wood-LedArk Invest Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD Shares May 29, 2024 Via Benzinga Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns May 27, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Monday's Pre-Market Session May 27, 2024 Via Benzinga Deckers Outdoor Posts Upbeat Earnings, Joins Guardant Health, Ross Stores And Other Big Stocks Moving Higher On Friday May 24, 2024 Via Benzinga FDA Advisory Panel Supports Approval Of Guardant Health's Blood Test For Colorectal Cancer Screening May 24, 2024 Via Benzinga Exposures Product Safety Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test May 24, 2024 Via Investor's Business Daily Exposures Product Safety FDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option May 23, 2024 From Guardant Health, Inc. Via Business Wire Guardant Health Stock Trading Temporarily Halted; FDA Panel to Assess Premarket Approval Application for Shield Blood Test for Colorectal Cancer Screening May 23, 2024 From Guardant Health, Inc. Via Business Wire Guardant Health to Participate in Upcoming Investor Conferences May 22, 2024 From Guardant Health, Inc. Via Business Wire What's Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday? May 21, 2024 Via Benzinga Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
